Citations (17)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Alice J. Abou-Nader, Molly A. Sauer, A. Duncan Steele, Jacqueline E. Tate, Deborah Atherly, Umesh D. Parashar, Mathuram Santosham & E. Anthony S. Nelson. (2018) Global rotavirus vaccine introductions and coverage: 2006 – 2016. Human Vaccines & Immunotherapeutics 14:9, pages 2281-2296.
Read now
Read now
Abdur Razzaque Sarker, Marufa Sultana, Rashidul Alam Mahumud, Robert Van Der Meer & Alec Morton. (2018) Cost-effectiveness analysis of introducing universal childhood rotavirus vaccination in Bangladesh. Human Vaccines & Immunotherapeutics 14:1, pages 189-198.
Read now
Read now
Sarah M Bartsch & Bruce Y Lee. (2014) Economics and financing of vaccines for diarrheal diseases. Human Vaccines & Immunotherapeutics 10:6, pages 1568-1581.
Read now
Read now
Auliya A Suwantika, Neily Zakiyah, Keri Lestari & Maarten J Postma. (2014) Accelerating the introduction of rotavirus immunization in Indonesia. Expert Review of Vaccines 13:4, pages 463-472.
Read now
Read now
Articles from other publishers (13)
Busara Charoenwat, Kunanya Suwannaying, Watuhatai Paibool, Napat Laoaroon, Sumitr Sutra, Kaewjai Thepsuthammarat & Suphasarang Sirirattanakul. (2023) The impact of rotavirus vaccination on acute diarrhea in Thai children under 5 years of age in the first year of universal implementation of rotavirus vaccines in the National Immunization Program (NIP) in Thailand: a 6-year analysis. BMC Public Health 23:1.
Crossref
Crossref
Xinyue Lu, Mengdi Ji, Abram L. Wagner, Weifeng Huang, Xiaoping Shao, Weiyu Zhou & Yihan Lu. (2022) Willingness to pay for HPV vaccine among female health care workers in a Chinese nationwide survey. BMC Health Services Research 22:1.
Crossref
Crossref
Tintu Varghese, Gagandeep Kang & Andrew Duncan Steele. (2022) Understanding Rotavirus Vaccine Efficacy and Effectiveness in Countries with High Child Mortality. Vaccines 10:3, pages 346.
Crossref
Crossref
Jessica Price, Jessica Mooney, Carolyn Bain, John Tanko Bawa, Nikki Gurley, Amresh Kumar, Guwani Liyanage, Rouden Esau Mkisi, Chris Odero, Karim Seck, Evan Simpson & William P. Hausdorff. (2022) National stakeholder preferences for next-generation rotavirus vaccines: Results from a six-country study. Vaccine 40:2, pages 370-379.
Crossref
Crossref
Lauren M Schwartz, K Zaman, Md Yunus, Ahasan-ul H Basunia, Abu Syed Golam Faruque, Tahmeed Ahmed, Mustafizur Rahman, Jonathan D Sugimoto, M Elizabeth Halloran, Ali Rowhani-Rahbar, Kathleen M Neuzil & John C Victor. (2019) Impact of Rotavirus Vaccine Introduction in Children Less Than 2 Years of Age Presenting for Medical Care With Diarrhea in Rural Matlab, Bangladesh. Clinical Infectious Diseases 69:12, pages 2059-2070.
Crossref
Crossref
Tharani LoganathanChiu-Wan NgWay-Seah LeeRaymond C W HutubessyStéphane VerguetMark Jit. (2018) Thresholds for decision-making: informing the cost-effectiveness and affordability of rotavirus vaccines in Malaysia. Health Policy and Planning 33:2, pages 204-214.
Crossref
Crossref
E Anthony S Nelson & A Duncan Steele. (2017) Vaccine Impact Data Should Support Country Decision Making. The Journal of Infectious Diseases 215:11, pages 1634-1636.
Crossref
Crossref
Piyanit Tharmaphornpilas, Suchada Jiamsiri, Somchit Boonchaiya, Onwipa Rochanathimoke, Wiravan Thinyounyong, Sumana Tuntiwitayapun, Ratigorn Guntapong, Arthorn Riewpaiboon, Aim-on Rasdjarmrearnsook & Roger I. Glass. (2017) Evaluating the first introduction of rotavirus vaccine in Thailand: Moving from evidence to policy. Vaccine 35:5, pages 796-801.
Crossref
Crossref
Shuhui Cui, Ruoyan Gai Tobe, Xiuting Mo, Xiaoyan Liu, Lingzhong Xu & Shixue Li. (2016) Cost-effectiveness analysis of rotavirus vaccination in China: Projected possibility of scale-up from the current domestic option. BMC Infectious Diseases 16:1.
Crossref
Crossref
Tharani Loganathan, Mark Jit, Raymond Hutubessy, Chiu-Wan Ng, Way-Seah Lee & Stéphane Verguet. (2016) Rotavirus vaccines contribute towards universal health coverage in a mixed public-private healthcare system. Tropical Medicine & International Health 21:11, pages 1458-1467.
Crossref
Crossref
Tharani Loganathan, Chiu-Wan Ng, Way-Seah Lee & Mark Jit. (2016) The Hidden Health and Economic Burden of Rotavirus Gastroenteritis in Malaysia. The Pediatric Infectious Disease Journal 35:6, pages 601-606.
Crossref
Crossref
Niamh HerlihyRaymond HutubessyMark Jit. (2016) Current Global Pricing For Human Papillomavirus Vaccines Brings The Greatest Economic Benefits To Rich Countries. Health Affairs 35:2, pages 227-234.
Crossref
Crossref
J.L. Pérez Rojo, A.M. Haro Pérez, M.P. Rodríguez Pérez, M.T. Santos Jiménez, M. de Frutos Serna & M.P. Giraldo Sánchez. (2015) Estudio observacional de las hospitalizaciones por rotavirus durante el período 2008-2013 en un área de salud. Vacunas 16:1, pages 12-17.
Crossref
Crossref